The association between proton pump inhibitors and increased risk of hyponatremia - a cohort study

被引：0
|
作者：
Treves, Nir [1 ]
Shik, Tali [2 ]
Raccah, Bruria [3 ]
Shefer, Galit [4 ]
Yoles, Israel [2 ]
Matok, Ilan [1 ]
机构：
[1] Hebrew Univ Jerusalem, Sch Pharm, Div Clin Pharm, Fac Med, Jerusalem, Israel
[2] Clalit Hlth Serv, Tel Aviv, Israel
[3] Hebrew Univ Jerusalem, Inst Drug Res, Sch Pharm, Div Clin Pharm,Fac Med, Jerusalem, Israel
[4] Kaplan Med Ctr, Rehovot, Israel
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2021年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：354 / 354
页数：1
相关论文
共 50 条
  • [41] Association Between Proton Pump Inhibitor Use and Anemia: A Retrospective Cohort Study
    Erin Sarzynski
    Chethan Puttarajappa
    Yan Xie
    Madhusudan Grover
    Heather Laird-Fick
    Digestive Diseases and Sciences, 2011, 56 : 2349 - 2353
  • [42] Increased mortality in patients with hematologic malignancies treated with proton pump inhibitors: a nationwide cohort study
    Vilmar, Adam
    Dehlendorff, Christian
    Friis, Soren
    Jaattela, Marja
    Tvingsholm, Siri
    Frederiksen, Henrik
    LEUKEMIA & LYMPHOMA, 2023, 64 (08) : 1451 - 1457
  • [43] Proton pump inhibitors and risk of gastric cancer: population-based cohort study
    Abrahami, Devin
    McDonald, Emily Gibson
    Schnitzer, Mireille E.
    Barkun, Alan N.
    Suissa, Samy
    Azoulay, Laurent
    GUT, 2022, 71 (01) : 16 - 24
  • [44] Proton pump inhibitors and risk of gastric cancer: a population-based cohort study
    A H Poulsen
    S Christensen
    J K McLaughlin
    R W Thomsen
    H T Sørensen
    J H Olsen
    S Friis
    British Journal of Cancer, 2009, 100 : 1503 - 1507
  • [45] Proton Pump Inhibitors and Risk of Acute and Chronic Kidney Disease: A Retrospective Cohort Study
    Hart, Emily
    Dunn, Terry E.
    Feuerstein, Steven
    Jacobs, David M.
    PHARMACOTHERAPY, 2019, 39 (04): : 443 - 453
  • [46] Proton pump inhibitors and risk of gastric cancer: a population-based cohort study
    Poulsen, A. H.
    Christensen, S.
    McLaughlin, J. K.
    Thomsen, R. W.
    Sorensen, H. T.
    Olsen, J. H.
    Friis, S.
    BRITISH JOURNAL OF CANCER, 2009, 100 (09) : 1503 - 1507
  • [47] Proton pump inhibitors use and the risk of fatty liver disease: A nationwide cohort study
    Pyo, Jeung Hui
    Kim, Tae Jun
    Lee, Hyuk
    Choi, Sung Chul
    Cho, Soo-Jin
    Choi, Yoon-Ho
    Min, Yang Won
    Min, Byung-Hoon
    Lee, Jun Haeng
    Kang, Minwoong
    Lee, Yeong Chan
    Kim, Jae J.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 (05) : 1235 - 1243
  • [48] Proton pump inhibitors and risk of gastric cancer: A population-based cohort study
    Abrahami, Devin
    McDonald, Emily G.
    Schnitzer, Mireille
    Barkun, Alan
    Suissa, Samy
    Azoulay, Laurent
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 13 - 14
  • [49] Letter: cohort study examining the association between proton pump inhibitor therapy and risk of hepatocellular carcinoma in Taiwan
    Liao, K. -F.
    Lai, H. -C.
    Lin, C. -L.
    Lai, S. -W.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (06) : 689 - 690
  • [50] Association between Proton Pump Inhibitor Use and Risk of Hepatocellular Carcinoma: A Korean Nationally Representative Cohort Study
    Kim, Soungmun
    Jeong, Seogsong
    Park, Sun Jae
    Chang, Jooyoung
    Choi, Seulggie
    Cho, Yoosun
    Ahn, Joseph C.
    Lee, Gyeongsil
    Son, Joung Sik
    Park, Sang Min
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (10)
12345